M Chan-Yeung, JH Chang, J Manfreda, A Ferguson and A Becker
Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, Canada.

Changes in symptom score and peak expiratory flow (PEF) and the use of medications during the first acute exacerbation of asthma were studied in 41 patients and matched controls who took part in a panel study. An acute exacerbation was defined as the presence of at least one of the following: any unscheduled physician visit, visit to an emergency room, or hospitalization for treatment of asthma; a decrease in PEF by 30% from the patient's best reading; an increase in asthma symptoms during the day and night for over 48 h and not responding to usual medications; and the commencement or doubling of the dose of oral or inhaled steroids for any of the foregoing reasons. Data from -9 to -7 d before the onset of an acute exacerbation were taken as the baseline data, with which the values of the subsequent 14 d were compared. Significant increases in symptoms occurred before a significant reduction in PEF. None of the patients had a decrease of more than 30% in PEF before the onset of symptoms. Daily variation in PEF was not significantly increased from the baseline. Our results suggest that PEF monitoring is not as sensitive as a symptom diary for revealing acute exacerbations of asthma, and that a 30% decrease in PEF is too stringent a criterion for defining an acute exacerbation.

This article has been cited by other articles:

				H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99. [Abstract] [Full Text] [PDF]

				M. A. Rank, G. W. Volcheck, J. T. C. Li, A. M. Patel, and K. G. Lim Formulating an Effective and Efficient Written Asthma Action Plan Mayo Clin. Proc., November 1, 2008; 83(11): 1263 - 1270. [Abstract] [Full Text] [PDF]

				E. D. Bateman, S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al. Global strategy for asthma management and prevention: GINA executive summary Eur. Respir. J., January 1, 2008; 31(1): 143 - 178. [Abstract] [Full Text] [PDF]

				J M FitzGerald and P G Gibson Asthma exacerbations {middle dot} 4: Prevention. Thorax, November 1, 2006; 61(11): 992 - 999. [Abstract] [Full Text] [PDF]

				D. Wensley and M. Silverman Peak Flow Monitoring for Guided Self-management in Childhood Asthma: A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 606 - 612. [Abstract] [Full Text] [PDF]

				J M FitzGerald, A Becker, M R Sears, S Mink, K Chung, and J Lee Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations Thorax, July 1, 2004; 59(7): 550 - 556. [Abstract] [Full Text] [PDF]

				P G Gibson and H Powell Written action plans for asthma: an evidence-based review of the key components Thorax, February 1, 2004; 59(2): 94 - 99. [Abstract] [Full Text] [PDF]

				E. R. McFadden Jr. Acute Severe Asthma Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759. [Abstract] [Full Text] [PDF]

				V Brusasco Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? Thorax, May 1, 2003; 58(5): 375 - 376. [Full Text]

				V. Bellia, F. Pistelli, D. Giannini, N. Scichilone, F. Catalano, M. Spatafora, R. Hopps, L. Carrozzi, S. Baldacci, F. Di Pede, et al. Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients Eur. Respir. J., May 1, 2003; 21(40_suppl): 21S - 27s. [Abstract] [Full Text] [PDF]

				M J Vaquerizo, P Casan, J Castillo, M Perpina, J Sanchis, V Sobradillo, A Valencia, H Verea, J L Viejo, C Villasante, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Thorax, March 1, 2003; 58(3): 204 - 210. [Abstract] [Full Text] [PDF]

				P. J. Sharek, M. L. Mayer, L. Loewy, T. N. Robinson, R. S. Shames, D. T. Umetsu, and D. A. Bergman Agreement Among Measures of Asthma Status: A Prospective Study of Low-Income Children With Moderate to Severe Asthma Pediatrics, October 1, 2002; 110(4): 797 - 804. [Abstract] [Full Text] [PDF]

				M. Weinberger, R. J. Scarfone, and J. J. Zorc Peak Flow Meter Use Is Not Where Emphasis Should Be Placed Arch Pediatr Adolesc Med, September 1, 2002; 156(9): 945 - 946. [Full Text] [PDF]

				M. L. Edmonds, C. A. Camargo Jr., B. E. Brenner, and B. H. Rowe Replacement of Oral Corticosteroids With Inhaled Corticosteroids in the Treatment of Acute Asthma Following Emergency Department Discharge* : A Meta-analysis Chest, June 1, 2002; 121(6): 1798 - 1805. [Abstract] [Full Text] [PDF]

				P. Lee, J. Abisheganaden, C.B.E. Chee, and Y.T. Wang A new asthma severity index: a predictor of near-fatal asthma? Eur. Respir. J., August 1, 2001; 18(2): 272 - 278. [Abstract] [Full Text] [PDF]

				J. CÔTÉ, D. M. BOWIE, P. ROBICHAUD, J.-G. PARENT, L. BATTISTI, and L.-P. BOULET Evaluation of Two Different Educational Interventions for Adult Patients Consulting with an Acute Asthma Exacerbation Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1415 - 1419. [Abstract] [Full Text]

				Asthma education and patient monitoring Can. Med. Assoc. J., November 1, 1999; 161(90111): s15 - 19. [Full Text]

				A. E. TATTERSFIELD, D. S. POSTMA, P. J. BARNES, K. SVENSSON, C.-A. BAUER, P. M. O'BYRNE, C.-G. LÖFDAHL, R. A. PAUWELS, and A. ULLMAN Exacerbations of Asthma . A Descriptive Study of 425 Severe Exacerbations Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 594 - 599. [Abstract] [Full Text]

				J. C. C. M.i.`t VEEN, H. H. SMITS, P. S. HIEMSTRA, A. E. ZWINDERMAN, P. J. STERK, and E. H. BEL Lung Function and Sputum Characteristics of Patients with Severe Asthma During an Induced Exacerbation by Double-Blind Steroid Withdrawal Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 93 - 99. [Abstract] [Full Text]

				C. L. Emerman, P. G. Woodruff, R. K. Cydulka, M. A. Gibbs, C. V. Pollack Jr., and C. A. Camargo Jr. Prospective Multicenter Study of Relapse Following Treatment for Acute Asthma Among Adults Presenting to the Emergency Department Chest, April 1, 1999; 115(4): 919 - 927. [Abstract] [Full Text] [PDF]

				L. Fabbri, B. Beghé, G. Caramori, A. Papi, and M. Saetta Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax, September 1, 1998; 53(9): 803 - 808. [Full Text]

				R. F. Lemanske Jr and W. W. Busse Asthma JAMA, December 10, 1997; 278(22): 1855 - 1873. [Abstract] [PDF]

				J. E. FISH, S. P. PETERS, C. V. CHAMBERS, S. J. MCGEADY, K. R. EPSTEIN, H. A. BOUSHEY, R. M. CHERNIACK, V. M. CHINCHILLI, J. M. DRAZEN, J. V. FAHY, et al. An Evaluation of Colchicine as an Alternative to Inhaled Corticosteriods in Moderate Asthma Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1165 - 1171. [Abstract] [Full Text] [PDF]